David Foehr Sells 5,556 Shares of CeriBell (NASDAQ:CBLL) Stock

CeriBell, Inc. (NASDAQ:CBLL) VP David Foehr sold 5,556 shares of the company’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $20.00, for a total transaction of $111,120.00. Following the completion of the transaction, the vice president owned 18,900 shares in the company, valued at approximately $378,000. The trade was a 22.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

David Foehr also recently made the following trade(s):

• On Monday, January 5th, David Foehr sold 5,556 shares of CeriBell stock. The shares were sold at an average price of $22.60, for a total transaction of $125,565.60.
• On Wednesday, December 3rd, David Foehr sold 5,265 shares of CeriBell stock. The stock was sold at an average price of $16.83, for a total transaction of $88,609.95.

CeriBell Stock Performance

CeriBell stock traded down $0.89 during mid-day trading on Thursday, reaching $19.27. 128,450 shares of the stock traded hands, compared to its average volume of 370,512. The business’s 50-day moving average is $21.05 and its 200-day moving average is $15.62. The stock has a market capitalization of $714.65 million, a PE ratio of -12.76 and a beta of 1.03. CeriBell, Inc. has a 12-month low of $10.01 and a 12-month high of $26.04. The company has a debt-to-equity ratio of 0.12, a current ratio of 12.65 and a quick ratio of 12.25.

CeriBell (NASDAQ:CBLL) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.06. CeriBell had a negative net margin of 63.35% and a negative return on equity of 29.63%. The company had revenue of $22.59 million for the quarter, compared to the consensus estimate of $21.78 million. As a group, sell-side analysts predict that CeriBell, Inc. will post -2.46 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on CBLL shares. Raymond James Financial started coverage on CeriBell in a research report on Tuesday, October 21st. They set a “strong-buy” rating and a $19.00 target price on the stock. BTIG Research reaffirmed a “buy” rating and set a $30.00 price target on shares of CeriBell in a report on Wednesday, January 28th. TD Cowen restated a “buy” rating on shares of CeriBell in a research report on Tuesday, December 9th. JPMorgan Chase & Co. lowered their price target on CeriBell from $21.00 to $17.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of CeriBell in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $24.67.

Institutional Investors Weigh In On CeriBell

Hedge funds have recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in CeriBell during the third quarter valued at $33,000. CWM LLC grew its stake in shares of CeriBell by 1,178.5% during the fourth quarter. CWM LLC now owns 1,841 shares of the company’s stock valued at $40,000 after buying an additional 1,697 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of CeriBell by 353.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock worth $43,000 after acquiring an additional 1,801 shares during the last quarter. Ameritas Investment Partners Inc. boosted its holdings in CeriBell by 97.5% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,544 shares of the company’s stock valued at $48,000 after acquiring an additional 1,256 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey increased its stake in CeriBell by 161.0% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 5,677 shares of the company’s stock worth $106,000 after purchasing an additional 3,502 shares during the period.

About CeriBell

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.